购物车
- 全部删除
- 您的购物车当前为空
Bimiralisib (PI3K-IN-2) 是一种有效的,可渗透脑的 mTOR/PI3K 抑制剂,是一种 mTORC1和 mTORC2抑制剂。它能够抑制 PI3Kα,PI3Kδ,PI3Kβ,PI3Kγ和 mTOR,IC50分别为 33 nM,451 nM,661 nM,708 nM 和 89 nM。
Bimiralisib (PI3K-IN-2) 是一种有效的,可渗透脑的 mTOR/PI3K 抑制剂,是一种 mTORC1和 mTORC2抑制剂。它能够抑制 PI3Kα,PI3Kδ,PI3Kβ,PI3Kγ和 mTOR,IC50分别为 33 nM,451 nM,661 nM,708 nM 和 89 nM。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 289 | 现货 | |
5 mg | ¥ 712 | 现货 | |
10 mg | ¥ 1,070 | 现货 | |
25 mg | ¥ 2,150 | 现货 | |
50 mg | ¥ 3,480 | 现货 | |
100 mg | ¥ 4,960 | 现货 | |
200 mg | ¥ 6,860 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 783 | 现货 |
产品描述 | Bimiralisib (PI3K-IN-2) is an orally bioavailable pan inhibitor of PI3K and inhibitor of the mTOR, with potential antineoplastic activity. PI3K-IN-2 inhibits the PI3K kinase isoforms alpha, beta, gamma and delta and, to a lesser extent, mTOR kinase, which may result in tumor cell apoptosis and growth inhibition in cells overexpressing PI3K/mTOR. Activation of the PI3K/mTOR pathway promotes cell growth, survival, and resistance to both chemotherapy and radiotherapy. |
靶点活性 | PI3Kα:1.5 nM(Kd), PI3Kγ:25 nM(Kd), mTOR:12 nM(Kd), PI3Kβ:11 nM(Kd), PI3Kδ:25 nM(Kd) |
别名 | PQR309, PI3K-IN-2, 5-(4,6-dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine |
分子量 | 411.38 |
分子式 | C17H20F3N7O2 |
CAS No. | 1225037-39-7 |
Smiles | Nc1cc(c(cn1)-c1nc(nc(n1)N1CCOCC1)N1CCOCC1)C(F)(F)F |
密度 | 1.418 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||
溶解度信息 | DMSO: 5 mg/mL (12.15 mM) | ||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容